Is Eli Lilly (LLY) a Buy on Tirzepatide Success in Sleep Apnea?

Eli Lilly (LLY) files for the approval of tirzepatide to treat obstructive sleep apnea in adults with obesity in the United States. If approved, sales of the blockbuster drug will rise further.